ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,321.41
      0.25%
      US Tech 100
      18,231.60
      0.19%
      Dow Jones
      39,872.99
      0.17%
      Brent Oil
      82.445
      -1.30%
      Bitcoin
      69,930.01
      -2.13%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Sigyn Therapeutics Inc (QB) (SIGY)

      7. Sigyn Therapeutics Inc (QB) (SIGY) News

      SIGY

      Sigyn Therapeutics (QB) (SIGY)

      Sigyn Therapeutics Inc (QB)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:SIGY
      DateTimeSourceHeadlineSymbolCompany
      01/31/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
      01/30/20244:23PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
      01/11/20243:25PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
      01/08/20242:34PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
      12/12/20232:48PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
      10/26/20233:23PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
      10/04/20235:10PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
      09/19/20233:56PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
      08/14/20233:35PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:SIGYSigyn Therapeutics Inc (QB)
      07/07/202311:15AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
      06/08/20232:38PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
      05/17/20237:15AMInvestorsHub NewsWireSigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep™ Trademark ApplicationUSOTC:SIGYSigyn Therapeutics Inc (QB)
      05/15/20235:35PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
      05/10/20235:27PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
      03/31/202310:06AMInvestorsHub NewsWireSigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-KUSOTC:SIGYSigyn Therapeutics Inc (QB)
      03/31/20236:19AMEdgar (US Regulatory)Annual Report (10-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
      02/28/20233:19PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
      12/23/20223:52PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
      11/14/20223:51PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
      09/14/202212:37PMInvestorsHub NewsWireSigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease PatientsUSOTC:SIGYSigyn Therapeutics Inc (QB)
      08/30/20226:09AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
      08/15/20226:32AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
      08/03/20227:07AMInvestorsHub NewsWireSigyn Therapeutics to Commence Trading on the OTCQB® Venture ExchangeUSOTC:SIGYSigyn Therapeutics Inc (QB)
      06/23/20226:02AMEdgar (US Regulatory)Securities Registration Statement (s-1)USOTC:SIGYSigyn Therapeutics Inc (QB)
      05/23/20225:00AMTipRanksAnalysts Are Bullish on These Healthcare Stocks: Sigyn Therapeutics (SIGY)USOTC:SIGYSigyn Therapeutics Inc (QB)
      03/21/20225:29PMEdgar (US Regulatory)Annual Report (10-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
      03/01/20225:28PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
      02/04/202210:48AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
      12/17/20218:48AMInvestorsHub NewsWireSigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapies Were Not Drugs or VaccinesUSOTC:SIGYSigyn Therapeutics Inc (QB)
      11/12/20214:49PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
       Showing the most relevant articles for your search:USOTC:SIGY